exberliner1 I think the ALTOA's are a little bit of stretch at 8c by September - I have a target of 6c short term.
That being said, we do have a few nice price catalysts in the mix at the moment that just may get it close:-
- Brazilian distribution agreement draft received. Increasing survey to encompass additional hospitals. Terms being negotiated. Cashflow positive result so very well could send share price 4 - 6c.
- Multinational US distributor requested and tested product with favorable result. Awaiting further news. Could well secure an MOU or Clinical trial in which case we get to know who.
- SE Asia distributors identified and meetings scheduled for coming month. Could well lead to LOI and trials similar to Brazil.
Options in the money would be nice, but for longer term I would much prefer to see Brazil signed, trials and LOI in SE Asia and to identify US major, perhaps secure trial.
- Forums
- ASX - By Stock
- ALT
- quarterly
quarterly, page-7
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online